Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2010-02-16 Annual Report
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
10-K/A FY 2008 AMENDMENT
Annual Report FY 2008
2010-02-16 English
10-K/A FY 2008 AMENDMENT
Annual Report FY 2008
2010-02-16 English
DIC IMAGING PRODUCTS AGREEMENT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated February 12, 2010. It announces the entry into a Master Manufacturing Agreement with DIC Imaging Products USA, LLC. The content focuses on the disclosure of a material definitive agreement rather than financial results, management changes, or other report types. The document length is 2951 characters, which is relatively short and primarily serves as an announcement of a contract agreement. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like Annual Report, Earnings Release, or M&A filings. Therefore, the appropriate classification is Regulatory Filings (RNS).
2010-02-12 English
10-Q 1ST QUATER FY 2010
Interim / Quarterly Report Q1 2010
2010-02-11 English
3RD QUARTER FY 2009 10-Q AMENDMENT
Interim / Quarterly Report Q2 2009
2010-02-10 English
10-K/A FY 2008 AMENDMENT
Annual Report FY 2008
2010-02-10 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.